CAPITAL STOCK |
12 Months Ended |
|---|---|
Dec. 31, 2021 | |
| Equity [Abstract] | |
| CAPITAL STOCK |
NOTE I – CAPITAL STOCK
The Company has authorized 15,000,000 shares of preferred stock, with a par value of $.001 per share. Of those shares, the Company has designated 215 shares as Series A preferred stock and 567 shares as Series B preferred stock. At December 31, 2021 and 2020, there were 185 shares of Series A and 52 shares of Series B outstanding, respectively.
As of December 31, 2021 and the date of this filing, following the closing of the VDA Transaction, the Company has authorized 475,000,000 shares of common stock with a par value of $.001 per share. As of December 31, 2020, there were 190,000,000 authorized shares of common stock with a par value of $.001 per share. As of December 31, 2021 and 2020, the Company had 136,311,335 shares of common stock issued and outstanding, respectively.
During the year ended December 31, 2021, no shares were issued. During the year ended December 31, 2020, the Company issued 320,844 shares of common stock to directors for services performed during 2020. These shares were valued at $18,000, which approximated the fair value of the shares when they were issued.
During the years ended December 31, 2021 and 2020, no warrants were exercised.
During the years ended December 31, 2021 and 2020, no shares of Series A or B preferred stock were converted to shares of common stock.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|